We not only show that such targeted delivery regresses aneurysms, but we also show that such therapy restores elastin lamina, decreases matrix metalloproteinase (MMPs), immunomodulating cytokine TGFβ1, and infiltration of activated macrophages at the aneurysmal site. Here, TGFB1 is linked to aneurysm.